ceftriaxone IV
Selected indexed studies
- Ceftriaxone by IV push. (Am J Emerg Med, 2021) [PMID:32741557]
- Subcutaneously administered antibiotics: a review. (J Antimicrob Chemother, 2022) [PMID:36374566]
- Intravenous Push Administration of Antibiotics: Literature and Considerations. (Hosp Pharm, 2018) [PMID:30147136]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Ceftriaxone and methicillin-susceptible staphylococcus aureus: a perspective from pharmacokinetics/pharmacodynamics studies. (2021) pubmed
- Ceftriaxone by IV push. (2021) pubmed
- Subcutaneously administered antibiotics: a review. (2022) pubmed
- Intravenous Push Administration of Antibiotics: Literature and Considerations. (2018) pubmed
- EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. (2010) pubmed
- Enterococcal endocarditis revisited. (2015) pubmed
- Intravenous Ceftriaxone for Syphilitic Uveitis. (2018) pubmed
- Salmonella-induced pericarditis. (2025) pubmed
- Outpatient parenteral antimicrobial therapy for patients with Enterococcus faecalis endocarditis using continuous infusion IV benzylpenicillin plus IV ceftriaxone. (2024) pubmed
- Evidence-based protocol for prophylactic antibiotics in open fractures: improved antibiotic stewardship with no increase in infection rates. (2014) pubmed